Revass Utama Medika

Magictouch

Category:

Nanolute Technology

NANOLUTE TECHNOLOGY is designed to improve the lipophilicity and bioavailability of Sirolimus

  • Phospholipid is a drug carrier with two lipophilic tails and one hydrophilic head.
  • Sirolimus is encapsulated in phospholipid with proprietary Nanolute technology.

 

Nanolute Technology

Conversion of Sirolimus drug into sub-micron sized particles

Nanocarriers created by encapsulation of sub-micron sized
Sirolimus drug into highly biocompatible drug
Carrier-phospholipid

Upon inflation of MagicTouch SCB at target site, nanocarriers
with Sirolimus drug inside gets transferred to the vessel wall
following the principle of co-efficient diffusion

Upon body pH variation, nanocarriers mimics the body lipids and
liberates Sirolimus

The sub-micron sized Sirolimus drug particles penetrate the
deepest layer of the vessel over a period

 

 

 

 

 

Unique Coating Technology

Drug carrier along with drug is coated on the unfolded balloon to achieve 100% coating on balloon surface
Unique and proprietary refolding mechanism facilitates better crossing profile

 

TECHNICAL SPECIFICATION

 

ORDERING INFORMATION